Brown Advisory Inc. Reduces Stock Holdings in Cardinal Health, Inc. $CAH

Brown Advisory Inc. trimmed its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 8.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 216,826 shares of the company’s stock after selling 18,917 shares during the quarter. Brown Advisory Inc. owned 0.09% of Cardinal Health worth $44,558,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Aventura Private Wealth LLC purchased a new position in Cardinal Health during the 4th quarter worth $25,000. Bank of Jackson Hole Trust purchased a new position in Cardinal Health during the 4th quarter worth $27,000. Jones Financial Companies Lllp grew its stake in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares during the last quarter. Palladiem LLC purchased a new position in Cardinal Health during the 4th quarter worth $28,000. Finally, JPL Wealth Management LLC acquired a new stake in Cardinal Health during the 3rd quarter worth about $31,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 1.2%

Shares of CAH stock opened at $226.52 on Tuesday. The stock has a market cap of $53.05 billion, a PE ratio of 34.64, a price-to-earnings-growth ratio of 1.22 and a beta of 0.52. The business has a 50-day simple moving average of $203.46 and a 200-day simple moving average of $208.92. Cardinal Health, Inc. has a 52-week low of $137.75 and a 52-week high of $233.60.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.38. The business had revenue of $60.94 billion during the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Sell-side analysts anticipate that Cardinal Health, Inc. will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be paid a $0.5158 dividend. The ex-dividend date is Wednesday, July 1st. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio (DPR) is presently 31.19%.

Analyst Upgrades and Downgrades

A number of analysts have commented on CAH shares. JPMorgan Chase & Co. lowered their price target on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a research report on Monday, May 4th. Leerink Partners reaffirmed an “outperform” rating and set a $275.00 price target on shares of Cardinal Health in a research report on Monday, March 9th. Barclays lifted their price target on Cardinal Health from $243.00 to $258.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 24th. Wells Fargo & Company lowered their price target on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Finally, Wall Street Zen cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Monday. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $246.93.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.